This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bernard Pirofsky, MD; Raymond Beaulieu, MD; Robert D. Goldman, MD

Arch Intern Med. 1973;132(2):171-174.

Abstract
Six patients with preexisting lymphoproliferative neoplastic diseases received purified antithymocyte antisera globulin. A mean dose of 1,784 mg was administered over a mean period of 54 days. Beneficial therapeutic effects on associated immunologically mediated diseases were seen in two of the four patients with such abnormalities. There was no evidence of a therapeutic response with this agent on the neoplastic process, although the white-blood cell count transiently fell in a single case of chronic lymphocytic leukemia. Severe immunodepression was created in all subjects. In spite of this, there was no suggestion of either tumor spread or accentuated neoplastic growth following therapy with this drug. Two subjects, who have been followed up for 24 and 43 months, respectively, since therapy, manifested no evidence of a detrimental effect on the malignant process.

Author Affiliations
Portland, Ore

From the Division of Immunology and Allergy, University of Oregon Medical School, Portland.

Footnotes
Received for publication Dec 18,1972; accepted Jan 23, 1973.

Reprint requests to 3181 SW Sam Jackson Park Rd, Portland, Ore 97201 (Dr. Pirofsky).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?